Fms-like tyrosine kinase 3 mutations in childhood acute leukemias and their association with prognosis

Asian Pacific Journal of Cancer Prevention

Volumn 11, Issue 4, 2010, Pages 923-927

  Karabacak, Bircan Hizli ^a   Erbey, Fatih ^a   Bayram, Ibrahim ^a   Yilmaz, Sema ^a   Acipayam, Can ^a   Kilinç, Yurdanur ^b   Tanyeli, Atila ^a  

^a CUKUROVA UNIVERSITY FACULTY OF MEDICINE   (Turkey)

^b Department of Pediatric Hematology ^*  (Turkey)

Author keywords

Acute leukemia; Childhood; FLT3 ITD; FLT3 TKD; Prognosis

Indexed keywords

EID: 78650704652     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Abu-Duhier FM, Goodeve AC, Wilson GA, et al (2000). FLT-3 internal tandem duplication mutations in adult acute myeloid leukaemia define a high-risk group. Br J Haematol, 111, 190-5.
2. Abu-Duhier FM, Goodeve AC, Wilson GA, et al (2001). Identification of novel FLT-3 Asp835 mutations in adult acute myeloid leukemia. Br J Haematol, 113, 983-8.
3. Birg F, Courcoul M, Rosnet O, et al (1992). Expression of the FMS/KIT-like gene FLT-3 in human acute leukemias of the myeloid and lymphoid lineages. Blood, 80, 2584-93.
4. Carrow CE, Levenstein M, Kaufmann SH, et al (1996). Expression of the hematopoietic growth factor receptor FLT3(STK-1/Flk2) in human leukemias. Blood, 87, 1089-96.
5. Fenski R, Flesch K, Serve S, et al (2000). Constituve activation of FLT3 in acute myeloid leukemia and its consequences for growth of 32D cells. Br J Haematol, 108, 322-30.
6. Frohling S, Schlenk RF, Breitruck J, et al (2002). Prognostic sigificance of activating FLT3 mutations in younger adults (16 to 60 years) with acute myeloid leukemia and normal cytogenetics: A study of the AML Study Group Ulm. Blood, 100, 4372-80.
7. Gari M, Abuzenadah A, Chaudhary A, et al (2008). Detection of FLT3 oncogene mutations in acute myeloid leukemia using conformation sensitive gel electrophoresis. Int J Mol Sci, 9, 2194-204.
8. Iwai T, Yokota S, Nakao M, et al (1999). Internal tandem duplication of the FLT-3 gene and clinical evaluation in childhood acute myeloid leukemia. The Children's Cancer and Leukemia Study Group, Japan. Leukemia, 13, 38-43.
9. Kondo M, Horibe K, Takahashi Y, et al (1999). Prognostic value of internal tandem duplication of the FLT3 gene childhood acute myelogenous leukemia. Med Pediatr Oncol, 33, 525-9.
10. Kottaridis PD, Gale RE, Frew ME, et al (2001). The presence of a FLT-3 internal tandem duplication in patients with acute myeloid leukemia (AML) adds important prognostic information to cytogenetic risk group and response to the first cycle of chemotherapy: Analysis of 854 patients from the United Kingdom medical research council AML 10 and 12 trials. Blood, 98, 1752-9.
11. Levis M, Small D (2003). FLT-3: ITDoes matter in leukemia. Leukemia, 17, 1738-52.
12. Meshinchi S, Woods WG, Stirewalt DL, et al (2001). Prevalence and prognostic significance of FLT-3 internal tandem duplication in pediatric acute myeloid leukemia. Blood, 97, 89-94.
13. Meshinchi S, Stirewalt DL, Alanzo TA, et al (2003). Activating mutations of RTK /ras signal transductionpathway in pediatric acute myeloid leukemia. Blood, 102, 1474-9.
14. Meshinchi S, Alanzo TA, Stirewalt DL, et al (2006). Clinical implications of FLT3 mutations in pediatric AML. Blood, 108, 3654-61.
15. Nakao M, Yokota S, Iwai T, et al (1996). Internal tandem duplication of the flt3 gene found in acute myeloid leukemia. Leukemia, 10, 1911-8.
16. Parcell BW, Ikeda AK, Simms-Waldrip T, et al (2006). FMS-like tyrosine kinase 3 in normal hematopoiesis and acute myeloid leukemia. Stem Cells, 24, 1174-84.
17. Peng HL, Zhang GS, Gong FJ, et al (2008). Fms-like tyrosine kinase (FLT)3 and FLT3 internal tandem duplication in different types of adult leukemia: Analysis of 147 patients. Croat Med J, 49, 650-9.
18. Schnittger S, Schoch C, Dugas M, et al (2002). Analysis of FLT-3 length mutations in 1003 patients with acute myeloid leukemia: correlation to cytogenetics, FAB subtype, and prognosis in the AMLCG study and usefulness as a marker for the detection of minimal residual disease. Blood, 100, 59-66.
19. Stacchini A, Fubini L, Severino A, et al (1996). Expression of type III receptor tyrosine kinases FLT3 and KIT and responses to their ligands by acute myeloid leukemia blasts. Leukemia, 10, 1584-91.
20. Thiede C, Steudel C, Mohr B, et al (2002). Analysis of FLT-3-activating mutations in 979 patients with acute myelogenous leukemia: Association with FAB subtypes and identification of subgroups with poor prognosis. Blood, 99, 4326-35.
21. Xu F, Taki T, Yang HW, et al (1999). Tandem duplication of the FLT-3 gene is found in acute lymphoblastic leukaemia as well as acute myeloid leukaemia but not in myelodysplastic syndrome or juvenile chronic myelogenous leukaemia in children. Br J Haematol, 105, 155-62.
22. Yamamoto Y, Kiyoi H, Nakano Y, et al (2001). Activating mutation of D835 within the activation loop of FLT-3 in human hematologic malignancies. Blood, 97, 2434-9.
23. Yanada M, Matsuo K, Suzuki T, et al (2005). Prognostic significance of FLT-3 internal tandem duplication and tyrosine kinase domain mutations for acute myeloid leukemia: A meta-analysis. Leukemia, 19, 1345-9.